All Access Articles |
- Altimmune Reports Positive Results in Phase 2b Trial for MASH Treatment | 2025-06-26 | PHARMACEUTICAL
- Altimmune Reports $150M Cash Holdings | 2025-05-13 | PHARMACEUTICAL
- Altimmune CFO Richard Eisenstadt Passes Away | 2024-06-26 | PHARMACEUTICAL